Eosinophils Target Therapy for Severe Asthma: Critical Points
نویسندگان
چکیده
منابع مشابه
Histamines, basophils and eosinophils in severe asthma.
1. Arterial and venous whole blood and plasma histamine concentrations and eosinophil and basophil counts were determined in five patients with acute severe asthma who had not previously received steroid therapy, in five who had been maintained on steroid therapy and in a control group of nine patients with acute non-respiratory illnesses. 2. No significant arteriovenous differences were observ...
متن کاملTailored therapy for severe asthma
Patients with severe asthma or COPD have often a suboptimal symptom control due to inadequate treatment. A better understanding of pathogenetic mechanisms, phenotypes, endotypes and the new technologies available in the fields of molecular biology and immunogenetics have made it possible to synthesize specific monoclonal antibodies virtually able to interact with any target antigen, or to open ...
متن کاملGlucocorticosteroid therapy in acute severe asthma--a critical review.
Glucocorticosteroid (GCS) therapy is one of the corner-stones in the treatment of asthma. Its value in acute severe asthma is still open for debate. Many of the papers published on the topic are subject to methodological problems. In 8 of 13 placebo-controlled studies, GCS therapy proved to be superior to placebo, evaluated either as result of pulmonary function, blood gas tension, or hospital ...
متن کاملMonodromy problem for the degenerate critical points
For the polynomial planar vector fields with a hyperbolic or nilpotent critical point at the origin, the monodromy problem has been solved, but for the strongly degenerate critical points this problem is still open. When the critical point is monodromic, the stability problem or the center- focus problem is an open problem too. In this paper we will consider the polynomial planar vector fields ...
متن کاملBiomarkers and severe asthma: a critical appraisal
Severe asthma (SA) is a clinically and etiologically heterogeneous respiratory disease which affects among 5-10 % of asthmatic patients. Despite high-dose therapy, a large patients percentage is not fully controlled and has a poor quality of life. In this review, we describe the biomarkers actually known in scientific literature and used in clinical practice for SA assessment and management: ne...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BioMed Research International
سال: 2018
ISSN: 2314-6133,2314-6141
DOI: 10.1155/2018/7582057